Received Nov 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | UNK | — |
Rash; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of rash in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, 2 months after receiving Shingles vaccine, the patient experienced rash (Verbatim: Rash). The outcome of the rash was not reported. It was unknown if the reporter considered the rash to be related to Shingles vaccine. It was unknown if the company considered the rash to be related to Shingles vaccine. Linked case(s) involving the same patient: US2025AMR153456 Additional Information: GSK Receipt Date: 26-NOV-2025 This case was reported by a patient via interactive digital media. Patient had received her shingles shot when he/she aged into insurance in 2024. Patient developed a rash about two months afterward. The doctor said it had nothing to do with the vaccine and patient disagreed. Patient had never had a rash before that, nor since. They said shingles had been worse and patient could agree with that.; Sender's Comments: US-GSK-US2025AMR153456:Case for 2nd dose/same patient